Literature DB >> 10857252

Genetic and environmental influences on transitions in drug use.

M T Tsuang1, M J Lyons, R M Harley, H Xian, S Eisen, J Goldberg, W R True, S V Faraone.   

Abstract

Genetic and environmental factors influence drug abuse, but abuse represents the culmination of a sequence of events. Different levels of use may have different determinants and these determinants may differ across drug types. Approximately 3200 male-male twin pairs from the Vietnam Era Twin Registry were interviewed by telephone. Data were obtained regarding exposure to six categories of illicit drugs, initiation of use, continuation of use, regular usage, and diagnosis of drug abuse/dependence. Genetic, common environmental, and unique environmental influences on transitions of drug involvement, defined as movement from one level of drug use to the next, were investigated. Marijuana had the highest conditional probability for the transition from exposure to use, from use to use more than five times, and from use more than five times to regular use. The rate of transition to regular use of heroin was higher than the rate for amphetamine, cocaine, sedatives, and psychedelics. Cocaine had the highest conditional probability for the transition from regular use to abuse/dependence. Significant genetic influences were observed for a number of transitions in marijuana, amphetamine, and cocaine usage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10857252     DOI: 10.1023/a:1021635223370

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  36 in total

1.  Needed: mouse/human cross validation of reinstatement/relapse models (and drug reward models) to model human substance abuse vulnerability allelic variants.

Authors:  George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2003-04-29       Impact factor: 4.530

Review 2.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  The association between prescribed opioid use for mothers and children: a record-linkage study.

Authors:  Tomas Log; Svetlana Skurtveit; Randi Selmer; Aage Tverdal; Kari Furu; Ingeborg Hartz
Journal:  Eur J Clin Pharmacol       Date:  2012-06-09       Impact factor: 2.953

Review 4.  Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin Registry.

Authors:  Kamini R Shah; Seth A Eisen; Hong Xian; Marc N Potenza
Journal:  J Gambl Stud       Date:  2005

Review 5.  Molecular genetics of addiction vulnerability.

Authors:  George R Uhl
Journal:  NeuroRx       Date:  2006-07

6.  Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions.

Authors:  Tomas Drgon; Claudio D'Addario; George R Uhl
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

7.  Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies.

Authors:  Gary A Heiman; Elizabeth Ogburn; Prakash Gorroochurn; Katherine M Keyes; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2007-10-22       Impact factor: 4.492

8.  Genetically correlated effects of selective breeding for high and low methamphetamine consumption.

Authors:  J M Wheeler; C Reed; S Burkhart-Kasch; N Li; C L Cunningham; A Janowsky; F H Franken; K M Wiren; J G Hashimoto; A C Scibelli; T J Phillips
Journal:  Genes Brain Behav       Date:  2009-07-21       Impact factor: 3.449

Review 9.  Predicting treatment outcome in stimulant dependence.

Authors:  Martina Reske; Martin P Paulus
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 10.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.